000			01861 a2200481 4500
005			20250516085318.0
264		0	_c20131118
008			201311s 0 0 eng d
022			_a1098-2744
024	7		_a10.1002/mc.21905 _2doi
040			_aNLM _beng _cNLM
100	1		_aYi, Yong Weon
245	0	0	_aInhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells. _h[electronic resource]
260			_bMolecular carcinogenesis _cSep 2013
300			_a667-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBRCA1 Protein _xdeficiency
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCaspase 3 _xgenetics
650	0	4	_aCaspase 7 _xgenetics
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMCF-7 Cells
650	0	4	_aMutation _xgenetics
650	0	4	_aPTEN Phosphohydrolase _xgenetics
650	0	4	_aPhosphatidylinositol 3-Kinases _xgenetics
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
700	1		_aKang, Hyo Jin
700	1		_aKim, Hee Jeong
700	1		_aHwang, Jae Seok
700	1		_aWang, Antai
700	1		_aBae, Insoo
773	0		_tMolecular carcinogenesis _gvol. 52 _gno. 9 _gp. 667-75
856	4	0	_uhttps://doi.org/10.1002/mc.21905 _zAvailable from publisher's website
999			_c21690495 _d21690495